drugset
drugset / Trial / NCT00978705

Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood

NCT00978705 ↗

Phase 3 Unknown 19 enrolled Biosolution Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The efficacy and safety of Autologous cultured keratinocyte cell on severe burn wound.

Timeline

Start
2007-11
Primary completion
2008-05
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous cultured keratinocyte cell Unknown 3e+07 cells —

Indications

No indication recorded.